AC Immune S.A. (ACIU) vs Anika Therapeutics, Inc. (ANIK)
A side-by-side comparison of AC Immune S.A. and Anika Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACIU
AC Immune S.A.
$2.68HealthcareDelayed quote: Oct 6, 2026, 9:34 AM EDT
ANIK
Anika Therapeutics, Inc.
$19.73HealthcareDelayed quote: Oct 6, 2026, 9:35 AM EDT
Total return — ACIU vs ANIK
growth of $100 · dividends reinvested · last 10yACIU -83.1% (-16.3%/yr)ANIK -57.8% (-8.3%/yr)ANIK compounded faster over this window
ACIU ANIK
ACIU vs ANIK: by the numbers
- •ACIU is the larger company ($273M vs $264M market cap).
- •Both run net losses; ANIK's is the smaller (-3.14% vs -249.94% net margin).
- •Both shrank revenue over the past five years; ANIK's decline was smaller (-2.48% vs -23.70% CAGR).
Metrics side by side
Valuation
| Metric | ACIU | ANIK |
|---|---|---|
| Forward P/E | N/A | 18.79 |
| P/S ratio | 12.57 | 2.19 |
| P/B ratio | 6.27 | 1.92 |
| EV / EBITDA | N/A | 489.09 |
| FCF yield | N/A | 0.21% |
Profitability
| Metric | ACIU | ANIK |
|---|---|---|
| Gross margin | 100.00% | 62.16% |
| Operating margin | -1927.32% | -4.24% |
| Net margin | -249.94% | -3.14% |
| ROE | -124.67% | -2.76% |
| ROIC | -89.43% | -3.17% |
Growth (annualized)
| Metric | ACIU | ANIK |
|---|---|---|
| Revenue CAGR (5Y) | -23.70% | -2.48% |
| FCF CAGR (5Y) | N/A | -39.38% |
| Total return CAGR (5Y) | -16.03% | -13.40% |
Frequently asked
- Which has grown faster, ACIU or ANIK?
- Neither grew: over the past five years both shrank revenue, with ANIK's decline the smaller — ACIU at a -23.70% CAGR versus ANIK at -2.48%.
- How have ACIU and ANIK total returns compared?
- Over the past 10 years, ACIU delivered -16.61% and ANIK delivered -8.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.